First New York Securities’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

First New York Securities’s Portfolio AVNR Stock Details AVNR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-561	Closed	-$262K	–	540
2014 Q4	$262K	Buy	+561	New	+$7.89K	0.47%	43

First New York Securities's AVNR Position: Q1 2015 in Review

First New York Securities sold out of AVANIR PHARMACEUTICALS, INC CL A (AVNR) in Q1 2015, closing a stake of 49,446 shares — an estimated $838K sold.

First New York Securities first reported a position in AVNR in Q4 2014 and held it in 1 quarter. The position peaked at $838K in Q4 2014. 0 funds tracked by Wall St. Rank hold AVNR as of Q1 2015.

First New York Securities reported no remaining AVANIR PHARMACEUTICALS, INC CL A position as of Q1 2015 after selling out during the quarter.
First New York Securities sold 49,446 AVANIR PHARMACEUTICALS, INC CL A shares in Q1 2015, an estimated $838K.
First New York Securities first reported a position in AVANIR PHARMACEUTICALS, INC CL A in Q4 2014 and held it in 1 quarter.
First New York Securities's AVANIR PHARMACEUTICALS, INC CL A position peaked at $838K in Q4 2014.
0 funds tracked by Wall St. Rank held AVANIR PHARMACEUTICALS, INC CL A as of Q1 2015.

Based on First New York Securities's 13F filing for Q1 2015, filed 6 May 2015.